Izmerov N F, Shpagina L A, Panacheva L A, Karmanovskaia S A, Kuznetsova G V, Karpenko A G
Med Tr Prom Ekol. 2011(1):7-11.
Recommendations for patients with occupational locomotory disorders include ultrasonography, diagnostic and therapeutic arthroscopy, target therapy of systemic osteoporosis with monohydrate zoledronic acid (aclasta)--that enables prolong remission (up to 46.2 months).
针对职业性运动系统疾病患者的建议包括超声检查、诊断性和治疗性关节镜检查、使用唑来膦酸一水合物（密固达）对全身性骨质疏松症进行靶向治疗，这可使缓解期延长（长达46.2个月）。
